FeesSafety
Pluang+

Enovis reports 2% sales growth in Q3 2026, raises full-year profit outlook, and approves $200M share buyback.

Company Fundamentals
05 Nov 2026, 13:00 WIB
GlobeNewsWire
View Source
Bullish
Enovis reports 2% sales growth in Q3 2026, raises full-year profit outlook, and approves $200M share buyback.

Enovis Corporation announced a 2% reported and 5% organic sales growth in Q3 2026, driven by a 6% increase in reconstructive sales. The company raised its full-year 2026 guidance for adjusted EBITDA and earnings per share, reflecting confidence in its innovation strategy and cost discipline. Additionally, Enovis' board approved a new $200 million share repurchase program to enhance shareholder value. The company continues investing in new technologies, including the planned acquisition of eCential Robotics, to support future growth.

Enovis Corporation's third quarter 2026 results provide context for readers interested in health sector trends. As of Nov 05, 2026 17:11 WIB, out of 150 priced health-sector US stocks tradable on Pluang, 82 rose and 59 fell. Notable movers include ADMA Biologics Inc (ADMA) with a price of USD 12.96 and a 1-day change of +23.66%, Cassava Sciences Inc (FLNA) at USD 0.63 with +9.21%, and Humana Inc (HUM) at USD 386.84 with a -7.33% change. The most notable figure is ADMA's 23.66% gain.

More News

Shell buys back over 1.8 million shares as part of its ongoing repurchase program.

Shell buys back over 1.8 million shares as part of its ongoing repurchase program.

On November 4, 2026, Shell plc repurchased a total of 1,876,276 shares across multiple trading venues including LSE, Chi-X, BATS, XAMS, CBOE, and TQEX. The shares were bought at prices ranging from £37.98 to £38.82 and €45.70 to €46.72, with an avera...

Company Fundamentals
Neutral
18 minutes ago
Dune completes SOC 2 Type II, boosting trust as tokenized assets hit $32.6B amid growing institutional blockchain use.

Dune completes SOC 2 Type II, boosting trust as tokenized assets hit $32.6B amid growing institutional blockchain use.

Dune has completed a SOC 2 Type II examination with no exceptions, providing institutional clients with verified assurance of its data security standards. This milestone comes as tokenized real-world assets doubled to $32.6 billion and stablecoin mar...

Market News
Bullish
18 minutes ago
Northern Discovery Metals completes acquisition of Cibola copper-gold project in British Columbia.

Northern Discovery Metals completes acquisition of Cibola copper-gold project in British Columbia.

Northern Discovery Metals has finalized the acquisition of a 100% interest in the Cibola copper-gold project in British Columbia from Orogen Royalties. The project covers about 3,567 hectares near Houston, BC, in a region known for porphyry copper de...

Company Fundamentals
Bullish
18 minutes ago
Opus Genetics completes dosing in Phase 1/2 trial for gene therapy targeting inherited retinal diseases

Opus Genetics completes dosing in Phase 1/2 trial for gene therapy targeting inherited retinal diseases

Opus Genetics has finished dosing the higher-dose Cohort 2 in its Phase 1/2 trial of OPGx-BEST1, a gene therapy for BEST1-related inherited retinal diseases like Best vitelliform macular dystrophy and autosomal recessive bestrophinopathy. Cohort 2 en...

Market News
Bullish
1 hour ago
Perimeter Group reports Q3 2026 net income of $304.5M, driven by strong sales and acquisitions.

Perimeter Group reports Q3 2026 net income of $304.5M, driven by strong sales and acquisitions.

Perimeter Group Inc. announced a net income of $304.5 million for Q3 2026, reversing a prior year loss of $90.7 million, with net sales up 24% to $389.9 million. Growth was driven by a 14% increase in Fire Safety sales and an 84% surge in Specialty P...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App